Alto Neuroscience, Inc. Common Stock (ANRO)
Cost of Revenue
$184.00K
TTM · Period ending: · USD
ANRO Cost of Revenue
Latest reported$184.00Kperiod ending
Latest reported$184.00Kperiod ending
ANRO Cost of Revenue ($145.00K → $184.00K)
Annual cost of revenue
High-resolution chart · PNG
ANRO cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 661,000 | |
| 502,000 | |
| 0 | |
| 342,000 | |
| 145,000 |